ATS Medical Announces Record Quarterly and Full Ye...(t loss ...),Health

Adjustments to reconcile net loss to net cash

used in operating activities:

Depreciation and amortization 4,622 1,924

Loss on disposal of equipment - 26

Stock compensation expense 1,454 1,103

Acquired in-process research and development 3,500 14,400

Impairment of intangibles 755 -

Deferred income taxes 95 -

Non-cash interest expense 546 463

Change in value of common stock appreciation

rights and convertible senior notes

derivative liabilities 554 (1,528)

Changes in operating assets and liabilities 1,939 1,456

Net cash used in operating activities (9,543) (9,830)

Investing activities

Maturities (purchases) of short-term

investments, net 1,903 (990)

Acquisition of assets of CryoCath

Technologies Inc. (21,074) -

Business acquisition costs,

net of cash acquired (1,791) (717)

Payments for technology licenses

and other intangibles (277) (521)

Purchases of furniture, machinery

and equipment (748) (1,208)

Other (36) -

Net cash used in investing activities (22,023) (3,436)

Financing activities

Advances on bank notes payable 8,600 1,500

Repayments on bank notes payable (2,327)
'/>"/>